Raymond James & Associates’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $6.22K | Hold |
|
|||||
|
2023
Q2 | $4.54K | Sell |
|
|||||
|
2023
Q1 | $13K | Sell |
|
|||||
|
2022
Q4 | $17.2K | Sell |
|
|||||
|
2022
Q3 | $23K | Buy |
|
|||||
|
2022
Q2 | $58K | Hold |
|
|||||
|
2022
Q1 | $21K | Sell |
|
|||||
|
2021
Q4 | $30K | Sell |
|
|||||
|
2021
Q3 | $532K | Sell |
|
|||||
|
2021
Q2 | $585K | Buy |
|
|||||
|
2021
Q1 | $644K | Sell |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|
|||||
|
2020
Q3 | $315K | Buy |
|
|||||
|
2020
Q2 | $348K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $585K | Buy |
|